The Indian Council of Medical Research (ICMR) has now issued a clarification on the matter related to fixing the last date for the Corona virus vaccine to be made by August 15 in India. The ICMR has said that the fast track vaccine will be made only under globally accepted regulations.

ICMR has tweeted its two-page statement that the safety and interest of the people of India is a top priority.

Actually the debate on the date of August 15 started after a memo written by ICMR Director General Dr. Balram Bhargava this week. In this, he had asked India's top clinical research agencies to launch the corona virus vaccine by Independence Day.

Now ICMR has issued a clarification on the statement of the Director General, saying, "The DG-ICMR letter was meant to avoid unnecessary red-tapism from researchers doing clinical trials so that necessary procedures are not missed and new participants can be recruited.''

Also, the red-tapism was not a hindrance in fast track permission to market new indigenous testing kits or Covid-19 related medicines. In the process of developing indigenous vaccine, it was also asked to avoid slow pace so that this phase can be completed soon and a population-based trial can be started.''

The ICMR has stated that the process of developing a fast track vaccine is being carried out under globally accepted regulations.

The ICMR states that the vaccine can be tested simultaneously on animals and humans.

Also, the trial of the vaccine will be conducted with hardly any difficulty and the Data Safety Monitoring Board can review it if required.

The Indian Council of Medical Research (ICMR) has hoped that the Corona vaccine being made in India should be launched by 15 August. ICMR said this by writing a letter to the institutions associated with the trial of this vaccine.

The indigenous vaccine is co-produced by ICMR and Hyderabad-based Bharat Biotech Company.

ICMR says that once the clinical trial is complete, this vaccine can be launched for the common people on 15 August, ie, the day of India's independence.

12 institutes in India have been selected for clinical trials. ICMR director Dr Balaram Bhargava wrote a letter to these 12 institutes on 2 July and said that they should take the clinical trials by 7 July.

In his letter, Dr. Bhargava wrote, "An agreement has been reached with the Bharat Biotech company for the fast-track trial of the vaccine created through ICMR to prevent corona. This vaccine has been created by extracting a strain from the coronavirus.

"After clinical trials, ICMR wants to provide this vaccine to the people by August 15. Bharat Biotech is also working on a war footing. But the success of this vaccine depends on the cooperation of the institutes that have been selected for clinical trial.''

(Click here for Android APP of IBTN. You can follow us on facebook and Twitter)

Share This News

About sharing